Visalytics
Visalytics
approved EB-2 (NIW)

Staff Scientist

Tumor Immunology · Taiwan · 2025-09-10

Processing Time
33 days
Decision Date
2025-09-10
Location
Oklahoma
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to develop advanced preclinical cancer models to evaluate the efficacy and immune responses of novel immunotherapies, including cancer vaccines and antibody-drug conjugates. This work focuses on optimizing rational combination strategies to improve clinical outcomes for patients with treatment-resistant and aggressive cancers. The endeavor aims to bridge the gap between laboratory discovery and clinical application to make therapies safer and more accessible.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses the public health challenge of treatment-resistant cancers, which is a matter of significant national importance.

2 Well-positioned to Advance the Endeavor Met

The petitioner's record of 11 publications, 260 citations, and support from the DoD and NCI demonstrates they are well-positioned for success.

3 Balance of Interests Met

The urgency of improving cancer outcomes and the petitioner's unique expertise make it beneficial to waive the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's 11 peer-reviewed journal articles, 260 citations, and 17 peer reviews, demonstrating significant influence in the field. The case was strengthened by evidence of funding from the Department of Defense and the National Cancer Institute, satisfying all three Dhanasar prongs. Expert testimony confirmed the petitioner's role in identifying new therapeutic targets essential for U.S. clinical advancements.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Grants
Conference Presentations
Judging Experience
Government Alignment

Similar Cases

Postdoctoral Researcher

Biotechnology · Mexico

WeGreened EB-2 (NIW) approved
Maryland 489 days 2022-08-22
The petitioner proposes to develop a highly quantitative understanding of the interactions between cancer cells and the immune system. He utilizes high-resolution microscopy, high-throughput flow cytometry, and mathematical modeling to design personalized cancer immunotherapies that are more effective than current treatments.
View Case

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
California 467 days 2025-02-25
The petitioner proposes to continue identifying and characterizing novel genes and pathways that influence tumor cell behavior. Her work focuses on improving the understanding of cancer pathogenesis and immunotherapy to accelerate the development of new therapeutic strategies.
View Case

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
California 124 days 2023-01-25
The petitioner proposes to continue developing state-of-the-art agonistic onco-immunologic approaches for therapeutic applications to progress next-generation tumor treatment, specifically targeting advanced and metastatic late-stage tumors. The work utilizes therapeutic cellular engineering and biologics techniques to improve cancer immunotherapies.
View Case

Others

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
New Jersey 180 days 2025-09-03
The petitioner proposes to combine molecular biology methods with innovative drug delivery systems to enhance immune recognition of cancer cells. Her work focuses on developing next-generation immunotherapies that provide highly effective and less toxic treatment options for patients.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Taiwan

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-09-10.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 33 days
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Taiwan All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist